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ABSTRACT
Introduction We compared diabetes incidence in South 
Asians aged ≥45 years in urban India (Chennai and Delhi) 
and Pakistan (Karachi), two low- income and middle- 
income countries undergoing rapid transition, with blacks 
and whites in the US, a high- income country.
Research design and methods We computed age- 
specific, sex- specific and body mass index (BMI)- specific 
diabetes incidence from the prospective Center for 
Cardiometabolic Risk Reduction in South Asia Study 
(n=3136) and the Atherosclerosis Risk in Communities 
Study (blacks, n=3059; whites, n=9924). We assessed 
factors associated with incident diabetes using Cox 
proportional hazards regression.
Results South Asians have lower BMI and waist 
circumference than blacks and whites (median BMI, kg/
m2: 24.9 vs 28.2 vs 26.0; median waist circumference, 
cm 87.5 vs 96.0 vs 95.0). South Asians were less insulin 
resistant than blacks and whites (age- BMI- adjusted 
homeostatic model assessment of insulin resistance, 
µIU/mL/mmol/L: 2.30 vs 3.45 vs 2.59), and more insulin 
deficient than blacks but not whites (age- BMI- adjusted 
homeostasis model assessment of β-cell dysfunction, 
µIU/mL/mmol/L: 103.7 vs 140.6 vs 103.9). Age- 
standardized diabetes incidence (cases/1000 person- 
years (95% CI)) in South Asian men was similar to black 
men and 1.6 times higher (1.37 to 1.92) than white men 
(26.0 (22.2 to 29.8) vs 26.2 (22.7 to 29.7) vs 16.1 (14.8 
to 17.4)). In South Asian women, incidence was slightly 
higher than black women and 3 times (2.61 to 3.66) the 
rate in white women (31.9 (27.5 to 36.2) vs 28.6 (25.7 
to 31.6) vs 11.3 (10.2 to 12.3)). In normal weight (BMI 
<25 kg/m2), diabetes incidence adjusted for age was 2.9 
times higher (2.09 to 4.28) in South Asian men, and 5.3 
times (3.64 to 7.54) in South Asian women than in white 
women.
Conclusions South Asian adults have lower BMI and 
are less insulin resistant than US blacks and whites, 
but have higher diabetes incidence than US whites, 
especially in subgroups without obesity. Factors other 
than insulin resistance (ie, insulin secretion) may play an 
important role in the natural history of diabetes in South 
Asians.
INTRODUCTION
South Asians, defined as people residing in 
or with origins in India, Pakistan, Bangla-
desh, Sri Lanka, Nepal, Bhutan and Maldives, 
comprise nearly 2 billion people globally 
(nearly 30% of the world population), and 
experience a high risk of developing type 2 
diabetes.1–4 This phenomenon, first observed 
in the diaspora who migrated to higher- 
income countries,5–7 has become acutely 
evident in the past few decades with urbaniza-
tion and industrialization of low- income and 
Significance of this study
What is already known about this subject?
 ► South Asians exhibit high prevalent type 2 diabetes, 
even at low body mass indices (BMI).
 ► Few longitudinal studies have compared incident 
diabetes in South Asians with other ethnic groups, 
across BMI distributions, and including measures 
of pathophysiology (insulin resistance, insulin 
secretion).
What are the new findings?
 ► Compared with US whites, South Asians experienced 
higher rates of incident diabetes, especially in sub-
groups without obesity.
 ► South Asians were less insulin resistant than com-
parable US blacks and whites.
 ► South Asians were more insulin deficient than US 
blacks and whites.
How might these results change the focus of 
research or clinical practice?
 ► Findings will influence screening guidelines, preven-
tion and therapeutic regimens for South Asians with 
type 2 diabetes, especially people without obesity, 
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middle- income countries, and with the dramatic rise in 
diabetes prevalence within South Asia itself, particularly 
in cities.8–12
A number of studies comparing South Asians with 
other groups have reported a higher diabetes prevalence 
in this population after accounting for age and body mass 
index (BMI).2 13–15 However, data on the incidence of 
diabetes in South Asians living in South Asia are limited. 
A few studies in urban South Asia have documented high 
incidence of type 2 diabetes in South Asians.16 17 Studies 
in Canada and the USA1 18 19 have revealed a higher inci-
dence of type 2 diabetes in South Asians, compared with 
Chinese, whites and blacks. However, prior studies have 
not had long duration or rigorous follow- up for incident 
diabetes and have lacked in population representative-
ness or in measures of insulin resistance and secretion.
Using data from the Center for Cardiometabolic Risk 
Reduction in South Asia Study (CARRS), we report the 
age- specific and BMI- specific incidence by sex for urban 
South Asians adults living in India and Pakistan. We 
compared diabetes incidence among South Asians (aged 
≥45 years) (n=3136) from CARRS with blacks (n=3059) 
and whites (n=9924) aged 45–64 years in the USA using 
data from the Atherosclerosis Risk in Communities 
(ARIC) study.
METHODS
Details of methods used in CARRS and ARIC20 21 are 
published elsewhere. Brief descriptions of study popula-
tion, harmonized analytical samples and measurements 
are provided below.
Study populations and analytical samples
Center for Cardiometabolic Risk Reduction in South Asia Study
CARRS is a representative sample of adult residents living 
in Chennai and Delhi (India) and Karachi (Pakistan), 
recruited in 2010–11, and followed for assessments in 
2012–13, 2013–14, 2014 and 2016–17. The first, second 
and fourth assessments were conducted in person and 
the third by telephone. As reported previously,20 CARRS 
used a population- based, multistage, cluster sampling 
design based on local administrative boundaries to 
recruit adult men and women to be representative of 
each city. At the first stage of sampling, 20 wards were 
randomly selected from the urban districts of each city. 
At the second stage of sampling, five census enumer-
ation blocks (CEBs) were selected. At the third stage, 
20 households were randomly selected. And the fourth 
and final stage, one age- eligible man and non- pregnant 
woman from each household was randomly selected 
using the Kish method. The participants with equal age- 
sex strata (20–45, 46–60, ≥60 years) were selected. The 
baseline data were collected on n=16 287 participants 
aged ≥20 years, however we analyzed only those whose 
age was ≥45 years at baseline in order to be comparable 
to ARIC (ie, excluded those <45 years, n=6853). The 
present analysis includes participants with baseline data 
collected between October 2010 and December 2011, 
excluding those with diabetes at baseline (n=2541) and/
or those with missing diabetes status (n=70). Participants 
with at least one follow- up assessment by February 2017 
(n=3136) were included. Median follow- up time (IQR) 
was 4.8 (3.8–5.1) years. Diabetes at baseline was defined 
as fasting plasma glucose (FPG) ≥7.00 mmol/L (126 mg/
dL), hemoglobin A1c (HbA1c) ≥6.5% (48 mmol/mol) 
or self- reported/physician diagnosed diabetes or glucose 
lowering medication use. A total of 2205 participants had 
impaired glucose tolerance (ie, FPG ≤100–125 mg/dL or 
HbA1c ≤5.7%–6.5%) at baseline.
Atherosclerosis Risk in Communities
The ARIC study is an ongoing, community- based cohort 
of 15 792 adults recruited from four communities in 
the USA: Forsyth County, North Carolina; Washington 
County, Maryland; suburbs of Minneapolis, Minnesota 
and Jackson, Mississippi. The ARIC Cohort Component 
began in 1987, and each ARIC field center randomly 
selected and recruited a cohort sample of approximately 
4000 individuals aged 45–64 years from a defined popu-
lation in their community, to receive extensive examina-
tions, including medical, social and demographic data. 
Follow- up also occurs semi- annually, by telephone, to 
maintain contact and to assess health status of the cohort. 
The first examination was done between 1987 and 1989 
when participants were aged 45–64 years. For these 
analyses, visit 1 (1987–1989) was baseline with follow- up 
through visit 4 (1996–1998) (median follow- up time: 8.8 
years, IQR 5.6–9.0 years). We excluded the small number 
of participants who reported race other than white 
or black (n=48), participants with prevalent diabetes 
defined as in CARRS above (n=1867) and those who 
were missing diabetes status (n=882). We also excluded 
those who were under the age of 45 at visit 1 (n=35). A 
total of 6351 participants had fasting glucose (at base-
line) between 100 and 125 mg/dL or HbA1c (at visit 2) 
between 5.7% and 6.5%. A total of 12 983 ARIC partici-
pants were included in the analysis (n=3059 blacks and 
n=9924 whites).
Measurements
Sociodemographic data, anthropometry (height, weight, 
waist circumference), history of smoking, diabetes status, 
family history of diabetes and measured systolic (SBP) 
and diastolic (DBP) blood pressures were available in 
both CARRS and ARIC. For the assessment of blood pres-
sure, in CARRS, participants were rested for 5 min, and 
blood pressure was measured twice using an electronic 
sphygmomanometer (Omron HEM-7080 and HEM- 
7080IT- E; Omron, Tokyo, Japan). A third measurement 
was taken if the difference between the first two systolic 
or diastolic measurements was >10 or 5 mm Hg, respec-
tively. The mean of last two readings (ie, second and 
third reading) was used for analysis. In ARIC, SBP and 
DBP were measured three times per participant using 
copyright.
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a standardized Hawksley random- zero instrument. The 
mean of the second and third measurement was used.
FPG was measured by hexokinase/kinetic method 
in Chennai and Delhi site and by glucose oxidase/end 
point method in Karachi in CARRS. HbA1c was measured 
by high- performance liquid chromatography (HPLC) 
method in all three sites with reagents from Bio- Rad Labo-
ratories, Hercules, California, USA certified by National 
Glycohemoglobin Standardization Program (NGSP) and 
traceability to Diabetes Control and Complications Trial. 
In ARIC, glucose was assayed by a hexokinase method in 
serum at visits 1 and 2 and in plasma at visits 3 and 4. 
Persons fasting <8 hours were excluded from baseline and 
follow- up. HbA1c was measured from frozen whole- blood 
samples collected at ARIC visit 2 only and were assayed 
using HPLC (Tosoh A1c 2.2 Plus Glycohemoglobin 
Analyzer method in 2003–2004 and Tosoh G7 method 
in 2007–2008, Tosoh, Tokyo, Japan) and standardized 
to the Diabetes Control and Complications Trial assay.22 
Serum insulin was measured at visit 1 by radioimmuno-
assay using an Insulin Kit (Cambridge Medical Diagnosis, 
Billerica, Massachusetts, USA). Among CARRS, serum 
insulin concentration was measured using the electro-
chemiluminesence method (COBAS E 411; Roche Diag-
nostics), and validation of CARRS insulin measurements 
against a US reference laboratory, the Northwest Lipid 
Metabolism and Diabetes Research Laboratories have 
been reported earlier.23
In both cohorts, lipids (low- density lipoprotein- 
cholesterol (LDL- c), high- density lipoprotein- cholesterol 
(HDL- c), triglycerides) were measured in fasting serum; 
LDL- c was calculated using the Friedewald equation, 
except when triglycerides were >4.52 mmol/L (400 mg/
dL). BMI was calculated as measured weight in kilo-
grams divided by measured height in meter squared. 
BMI was categorized as <25; 25–29.9 and ≥30 kg/m2 
(normal weight, overweight and obese). Homeostasis 
model assessment of insulin resistance (HOMA- IR) was 
calculated as=fasting insulin (µIU/L)×fasting glucose 
(nmol/L)/22.5 or (I0 (µIU/mL)×G0 (mmol/L)/22.5); 
and homeostasis model assessment of β-cell dysfunc-
tion (HOMA- B) for insulin secretion was calculated 
as=(20×insulin)/(glucose−3.5) or (20×I0 (µIU/mL)/G0 
(mmol/L)−3.5).24
Incident diabetes
In the CARRS and ARIC cohorts, incident diabetes was 
defined as FPG ≥7.00 mmol/L (126 mg/dL), HbA1c 
≥6.5% (48 mmol/mol) or self- reported/physician diag-
nosed diabetes or on medication during follow- up. 
Additional analyses using only the FPG criteria was also 
undertaken.
Statistical analysis
Baseline characteristics among South Asians, US blacks 
and US whites were compared. Data were presented as 
mean (SD), median (IQR) or percentages as appropriate. 
The median test was used to compare the difference in 
median values between South Asians versus US blacks 
and South Asians versus US whites. To compare the 
difference in proportions, χ2 test was used. Per cent inci-
dence rates with 95% CIs were computed. Person- years 
were estimated from the date of enrolment to the time 
of diabetes diagnosis or the last date of visit or death, 
whichever was documented earlier. Age- specific inci-
dence (cases/1000 person- years) by sex and ethnicity 
was calculated. Age- standardized diabetes incidence (per 
1000 person- years) using the world age distribution by 
sex25 was also reported.
BMI- specific incidence (cases/1000 person- years) 
of diabetes, adjusted for age and stratified by sex and 
ethnicity, was calculated using Poisson models. The rela-
tive risk (incidence rate ratio (IRR)) and absolute risk 
(incidence rate difference (IRD)) comparing South 
Asians or US blacks minus US whites (US whites as 
referent group) and 95% CIs were estimated. Multivari-
able Cox proportional hazards models were used to assess 
the associations of HOMA- IR and HOMA- B with inci-
dent diabetes, separately in CARRS and ARIC. We tested 
for linear association of incident diabetes with age and 
BMI. Unlike BMI, age did not have a linear association 
with diabetes. Therefore, in the final adjusted model we 
included age and a quadratic term for age, gender, BMI, 
HOMA- IR (z- score) and HOMA- B (z- score). Proportion-
ality hazards assumptions (proportionality, interaction 
among predictors, time dependence) were evaluated, 
and were satisfied.
We conducted supplementary analyses among 
those without self- reported diabetes and with FPG 
<7.00 mmol/L (126 mg/dL) at baseline, with incident 
diabetes defined as those with FPG ≥7.00 mmol/L (126 
mg/dL), or self- reported/physician- diagnosed diabetes, 
or medication use at any time during follow- up. We 
undertook these supplementary analyses as HbA1c may 
vary by ethnicity.
All analyses were conducted using Stata V.16.0 (College 
Station, Texas, USA).
RESULTS
At baseline (table 1), the median age (years) of South 
Asians, US blacks and US whites were comparable (52.0 
vs 52.0 vs 54.0). Overall, South Asians had lower median 
BMI and waist circumference, lower levels of HDL- c, 
LDL- c, higher levels of triglycerides, SBP, DBP and lower 
fasting insulin than blacks and whites and there was 
significant difference between South Asian versus blacks 
and South Asian versus whites (table 1). South Asians 
were less insulin resistant than blacks and whites (age- 
BMI- adjusted HOMA- IR, µIU/mL/mmol/L: 2.30 vs 3.45 
vs 2.59, South Asian vs blacks p<0.001; South Asian vs 
whites p<0.001), South Asians were secreting less insulin 
than blacks but not whites (age- BMI- adjusted HOMA- B, 
µIU/mL/mmol/L: 103.7 vs 140.6 vs 103.9, South Asian 
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The median (IQR) duration of follow for South Asians, 
blacks and whites was 4.8 (3.8, 5.1); 8.6 (5.6, 8.8) and 8.9 
(8.7, 9.0), respectively. Among 3136 South Asians without 
diabetes at baseline (52.5% men), 389 incident cases 
of diabetes developed during the follow- up (table 2). 
Among 3059 US blacks without diabetes at baseline 
(37.8% men), 588 incident cases of diabetes developed 
during the follow- up, and among 9924 US whites without 
diabetes (46.6% men), 1036 incident cases of diabetes 
developed during the follow- up.
Age- standardized diabetes incidence (cases/1000 
person- years, 95% CI) in South Asian men was similar to 
US black men, but higher compared with US white men 
(IRR (95% CI) 26.0 (22.2 to 29.8) vs 26.2 (22.7 to 29.7) vs 
16.1 (14.8 to 17.4), respectively). In women, South Asians 
had a slightly higher incidence of diabetes compared with 
US black women (IRR (95% CI) 31.9 (27.5 to 36.2) vs 28.6 
(25.7 to 31.6) vs 11.3 (10.2 to 12.3), respectively). The 
diabetes incidence was 1.6 times higher in South Asian 
men (IRR (95% CI) 1.62 (1.37 to 1.92)) as compared 
with US white men but approximately 3 times higher in 
South Asian women (IRR (95% CI) 3.09 (2.61 to 3.66)) as 
compared with US white women. The absolute risk differ-
ence of incident diabetes (cases/1000 person years) was 
Table 1 Characteristics of study populations without diabetes in the CARRS (2010–2011) and ARIC (1987–1989) cohorts
Variables South Asians (n=3136) US blacks (n=3059) US whites (n=9924)
Age, years 52.0 (47.0, 60.0) 52.0 (48.0, 58.0) 54.0 (49.0, 59.0)†
Age categories (years), (%)   
  45–49 36.4 34.6‡ 26.0†
  49–54 22.5 26.8 26.6
  55–59 14.2 21.2 25.1
  ≥60 26.8 17.5 22.3
Men, (%) 52.7 37.8‡ 46.6†
Current smoker, (%) 16.9 29.7‡ 23.9†
Current drinker, (%) 14.4 33.8‡ 66.3†
Family (parental) history of diabetes, (%) 17.2 24.7‡ 21.9†
BMI, kg/m2 24.9 (21.7, 28.4) 28.2 (25.1, 32.1)‡ 26.0 (23.4, 29.1)†
BMI categories, kg/m2 (%)   
  <25.0 50.6 23.8‡ 39.4†
  25.0–29.9 32.4 39.6 40.4
  ≥30 17 36.6 20.2
Waist, cm 87.5 (79.0, 96.0) 96.0 (88.0, 106.0)‡ 95.0 (86.5, 103.0)†
HbA1c, mmol/mol* 40.0 (37.0, 42.0) 39 (36.0, 42.0)‡ 36 (33.0, 38.0)†
HbA1c, %* 5.8 (5.5, 6.0) 5.7 (5.4, 6.0)‡ 5.4 (5.2, 5.6)†
FPG, mmol/L 5.27 (4.94, 5.66) 5.44 (5.08, 5.82)‡ 5.44 (5.13, 5.77)†
Triglycerides, mmol/L 1.36 (1.03, 1.85) 1.02 (0.77, 1.40)‡ 1.25 (0.90, 1.79)†
LDL- c, mmol/L 2.98 (2.43, 3.52) 3.45 (2.78, 4.21)‡ 3.50 (2.91, 4.52)†
HDL- c, mmol/L 1.11 (0.96, 1.32) 1.37 (1.14, 1.70)‡ 1.27 (1.02, 1.57)
SBP, mm Hg 126.0 (114.5, 140.5) 124.0 (113.0, 137.0)‡ 116.0 (106.0, 127.0)†
DBP, mm Hg 83.0 (76.0, 91.0) 79.0 (72.0, 87.0)‡ 71.0 (65.0, 78.0)†
Fasting insulin, pmol/L§ 56.3 (36.8, 83.3) 79.2 (50.0, 114.6)‡ 57.6 (43.1, 86.1)
HOMA- IR, µIU/mL×mmol/L, 1.9 (1.2, 3.0) 2.7 (1.8, 4.3)‡ 2.1 (1.4, 3.2)†
HOMA- B, µIU/mL/mmol/L, 87.6 (59.6, 129.7) 118.7 (78.8, 172.4)‡ 90.1 (62.0, 127.4)†
Data are presented as median (IQR Q1, Q3) or %.
Diabetes defined as FPG ≥7.00 mmol/L (126 mg/dL) or HbA1c ≥48 mmol/mol (6.5%) or self- reported/physician- diagnosed diabetes or medication.
P value calculated using median test for comparing median values and χ2 test for categorical variables.
HOMA- B=(20×insulin)/(glucose−3.5) or (20×I0 (µIU/mL)/G0 (mmol/L)−3.5). HOMA- IR=fasting insulin (µIU/L)×fasting glucose (nmol/L)/22.5 or (I0 (µIU/
mL)×G0 (mmol/L)/22.5).
Family history=diabetes mellitus in father or mother.
*HbA1c in US blacks and whites was assessed 3 years after baseline in 1990–1992.
†Shows significant difference between South Asians versus US whites.
‡Shows significant difference between South Asians versus US blacks.
§Insulin in South Asians only in Chennai and Delhi samples (n= 1835).
ARIC, Atherosclerosis Risk in Communities; BMI, body mass index; CARRS, Center for Cardiometabolic Risk Reduction in South Asia Study; DBP, 
diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL- c, high- density lipoprotein- cholesterol; HOMA- B, homeostasis 
model assessment of β-cell dysfunction; HOMA- IR, homeostatic model assessment of insulin resistance; LDL- c, low- density lipoprotein- cholesterol; 
ns, not significant; SBP, systolic blood pressure.
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higher in South Asian men (IRD (95% CI 10.1 (6.1 to 
14.2)) and women (IRD (95% CI) 22.4 (17.8 to 27.0)) as 
compared with US white men and women, respectively.
In those with BMI <25 kg/m2 (table 3), risk of diabetes 
in men was 3 times higher in South Asians (IRR (95% CI) 
2.99 (2.09 to 4.28)) and 2.1 times higher in US blacks 
(IRR (95% CI) 2.11 (1.35 to 3.25)) as compared with 
US whites. Similarly, in women, the risk of diabetes in 
those with BMI <25 kg/m2 was 5.3 times higher in South 
Asian (IRR (95% CI) 5.27 (3.64 to 7.54)) and 2.5 times 
higher in US blacks (IRR (95% CI) 2.36 (1.56 to 3.78)) as 
compared with US whites. The absolute number of inci-
dent cases/1000 person- years was higher in South Asian 
men (IRD (95% CI) 12.5 (7.7 to 17.2)) and women (IRD 
(95% CI 17.9 (11.7 to 24.2)) as compared with US whites 
men and women with BMI <25 kg/m2.
In those with BMI ≥30 kg/m2 (table 3), diabetes incidence 
in South Asian men was 1.21 (0.76, 1.84) times higher than 
in US white men and in South Asian women, diabetes inci-
dence was 2.1 (1.56, 2.74) times higher than in US white 
women (table 3). The absolute diabetes risk was higher in 
South Asian women than in US white women (IRD (95% CI 
17.9 (11.7 to 24.2)) with BMI >30 kg/m2.
In multivariable Cox models (table 4), associations 
between age, sex, BMI and family history of diabetes 
with diabetes risk were similar in South Asians, US whites 
and US blacks. Family history of diabetes was signifi-
cantly associated with incident diabetes among black and 
white Americans but not among South Asians. For the 
association with diabetes, South Asians had the lowest 
HR for HOMA- IR (HR for 1 SD (95% CI) South Asian: 
2.67 (2.05 to 3.48); blacks: 14.55 (11.11 to 19.07); whites: 
34.64 (27.63 to 43.42)) and largest HR for HOMA- B (HR 
(95% CI) South Asian: 0.44 (0.34 to 0.58); blacks: 0.08 
(0.06 to 0.11); whites: 0.05 (0.04 to 0.06)).
Patterns of association were similar in sensitivity anal-
yses using a more specific definition of diabetes based 
on FPG ≥7.00 mmol/L (126 mg/dL) or glucose- lowering 
medication use (online supplemental table). These addi-
tional analyses also confirmed that although HbA1c may 
vary by ethnicity and was not available in the ARIC cohort 
at the first visit, this did not impact the pattern of differ-
ences in diabetes incidence between ethnicities.
DISCUSSION
Our prospective analyses, using data from two well- 
established cohorts (the CARRS and ARIC studies), 
confirm that South Asian adults living in urban India 
and Pakistan are, on average, less obese than blacks and 
whites in the USA, yet have higher diabetes incidence 
than US whites. This difference was more pronounced in 
women compared with men, and was also more marked 
in those with low BMI. Contrary to the widely held view 
that South Asians have a high propensity to insulin resis-
tance,5 6 26–28 our results are consistent with South Asians 
being less insulin resistant than US blacks or whites. 
These findings suggest that obesity and insulin resistance 
may not be the driving factors behind the high incidence 
of diabetes in South Asians, and impaired insulin secre-
tion may be more important.
There are several studies indicating that South Asians 
have a higher prevalence of diabetes even at lower BMI 
compared with other race/ethnic groups.1–4 A study 
assessing diabetes prevalence in New York City by race/
ethnicity noted that South Asians with normal BMI had 
nearly five times the diabetes prevalence of comparable 
normal weight whites, and more than double the preva-
lence of overweight whites.2 Similarly, a study assessing 
diabetes prevalence by weight category in US immi-
grants found that normal weight South Asians had nearly 
twice the diabetes prevalence of overweight European 
immigrants.4 Few studies have also examined the inci-
dence rate of diabetes among South Asians compared 
with other race/ethnic groups by BMI category. A study 
comparing the incidence rates of diabetes across race/
ethnic groups and BMI strata in Ontario, Canada found 
that the incidence rate of diabetes was 3 times higher in 
normal weight (BMI 18.5–25 kg/m2) South Asians than in 
white Canadians.1 Our study adds further evidence to the 
notion that South Asians are at high risk for diabetes at 
low BMI by indicating that in those with BMI <25 kg/m2, 
the risk of diabetes incidence was 3 and 5.3 times higher 
in South Asian men and women, respectively compared 
Figure 1 Mean values for HOMA- IR (µIU/mL×mmol/L) 
and HOMA- B (µIU/mL/mmol/L) adjusted by age and age/
BMI. BMI, body mass index; HOMA- B, homeostasis model 
assessment of β-cell dysfunction; HOMA- IR, homeostatic 
model assessment of insulin resistance.
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with whites. The reasons for the high risk of diabetes in 
South Asians is likely multifactorial, reflecting genetic, 
epigenetic, lifestyle factors, together with differences in 
pathophysiological mechanisms.
While earlier studies have noted high levels of insulin 
resistance in South Asians,5 6 26–28 increasing evidence 
suggest that South Asians have an innate susceptibility 
to defects in insulin secretion. Cross- sectional studies 
from Chennai, India, have noted that South Asians have 
reduced insulin secretion, even at mild levels of dysgly-
cemia.29 In young adults, dysfunction in insulin secretion, 
more so than insulin resistance, appears to be closely 
associated with diabetes.30 As South Asian adults have 
impaired early phase insulin release, consistently across 
all weight status classes, as reflected in the first 30 min of 
an oral glucose tolerance test, existing evidence suggests 
that pathways of disease development may emphasize 
pathways related to deficient insulin secretion, impaired 
fasting glucose and possibly exacerbated by ectopic 
hepatic and intramyocellular fat accumulation.23 31 A 
study assessing the associations of insulin secretion and 
insulin resistance on glycemic status in South Asians 
living in the USA found that after accounting for visceral 
fat, poor insulin secretion was more strongly associated 
with hyperglycemia than was insulin resistance.32 In our 
study, we found that South Asians were less insulin resis-
tant than both whites and blacks, and less insulin secre-
tion than black participants. This coupled with the high 
incidence rates of diabetes in South Asians adds further 
evidence that insulin secretion may be the primary and 
relatively more important defect driving diabetes risk in 
this race/ethnic population. This has major implications 
for ethnicity- specific diabetes treatment guidelines.33
Our study has several limitations that should be taken 
into account in interpreting these results. Although both 
CARRS and ARIC were population- based cohorts, they 
were assembled at different time period using different 
sampling methodologies, and also CARRS was purely 
urban, while ARIC was largely urban and suburban. 
Our comparison of diabetes incidence in South Asians 
with blacks and whites was restricted to ages ≥45 years 
as the ARIC cohort only recruited people aged 45 years 
and over. This limits our ability to examine the differ-
ences between younger South Asians and comparably 
aged blacks and whites, which may be important as 
South Asians have high diabetes prevalence at younger 
ages.13 15 34 35 Indeed, at baseline in our analysis, South 
Asians had a higher prevalence of diabetes, and thus we 
may be underestimating diabetes incidence in this cohort 
as a smaller at- risk group was followed. However, we 
found that across all ages from 45 years up, South Asians 
had a higher diabetes incidence than whites, and this was 
especially marked at lower BMIs. Our analysis primarily 
relied on BMI as a measure of body composition, and this 
measure does not fully capture body fat distribution.36–38 
However, additional analysis using waist circumference 
(online supplemental table S5) as a measure of central 
adiposity found similar differences between South Asians 
and blacks and whites in diabetes incidence across the 
distribution of adiposity.
To ensure comparability of end points, we used the 
same definition of diabetes across the two studies and 
relied on person- years of follow- up to standardize inci-
dence estimates. In ARIC, HbA1c was not available at 
baseline; however, sensitivity analyses restricting the 
comparison to only self- reported diabetes or fasting 
blood glucose ≥7.00 mmol/L (126 mg/dL) found similar 
patterns of differences between the ethnic groups. A 
limitation was that the CARRS and ARIC cohorts were 
initiated at different time periods and have some differ-
ences in follow- up, but our primary measure is incidence 
per 1000 person- years, and the focus of our comparison 
is around biological variables. Furthermore, the rise in 
diabetes in low- income and middle- income countries, 
like India and Pakistan, has happened over the past two 
decades, and no earlier cohorts exist.
Our study also has significant strengths. Both CARRS 
and ARIC are well- established and well- retained cohort 
studies of high quality, with standardized data collec-
tion, and multiple time points of follow- up for rigorous 
Table 4 Factors associated with diabetes incidence by ethnicity, Cox proportional hazards analysis
Variables
South Asians US blacks US whites
HR (95% CI) HR (95% CI) HR (95% CI)
Age 0.98 (0.82 to 1.18) 1.05 (0.77 to 1.43) 1.03 (0.82 to 1.30)
Age square 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Sex (men) 0.89 (0.66 to 1.19) 1.00 (0.83 to 1.20) 0.98 (0.86 to 1.11)
BMI (per unit) 1.05 (1.02 to 1.08) 1.04 (1.02 to 1.05) 1.06 (1.04 to 1.07)
Family (parental) history of diabetes (yes) 1.23 (0.86 to 1.75) 1.37 (1.14 to 1.65) 1.53 (1.35 to 1.75)
Log HOMA- IR (per SD) 2.67 (2.05 to 3.48) 14.55 (11.11 to 19.07) 34.64 (27.63 to 43.42)
Log HOMA- B (per SD) 0.44 (0.34 to 0.58) 0.08 (0.06 to 0.11) 0.05 (0.04 to 0.06)
Diabetes defined as FPG ≥7.00 mmol/L (126 mg/dL) or HbA1c ≥48 mmol/mol (6.5%) or self- reported/physician- diagnosed 
diabetes or medication.
BMI, body mass index; FPG, fasting plasma glucose; HOMA- B, homeostasis model assessment of β-cell dysfunction; 
HOMA- IR, homeostatic model assessment of insulin resistance; HR, hazard ratio.
copyright.
 on A














are: first published as 10.1136/bm





9BMJ Open Diab Res Care 2021;9:e001927. doi:10.1136/bmjdrc-2020-001927
Epidemiology/Health services research
assessment of diabetes. Our study also examined diabetes 
incidence across the full distribution of BMI, used 
rigorous capture of incident diabetes and had longitu-
dinal follow- up. Furthermore, we included measures 
of insulin resistance and secretion (ie, HOMA- IR and 
HOMA- B), which are validated against gold standards, 
and are considered reasonable for population studies.39 40
In conclusion, in this study of prospective data from 
two longitudinal cohorts, we found that the incidence 
of diabetes among South Asian adults is higher than US 
whites, and markedly so in people without obesity. Our 
results are also consistent with South Asians being less 
insulin resistant than US blacks or whites. Factors other 
than obesity and insulin resistance (eg, innate insulin 
deficiency) may thus be important in the risk of diabetes 
in South Asians. Screening, prevention and treatment 
guidelines may need to be tailored more appropriately to 
address the mechanisms of disease risk in South Asians.
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